Kaarthika Thottikat, Radhapuram Sri Devi, Samantaray Aloka, Pasupuleti Hemalatha, Hanumantha Rao Mangu, Bharatram R
Department of Anaesthesiology and Critical Care Medicine, Sri Venkateswara Institute of Medical Sciences (SVIMS), Tirupati, Andhra Pradesh, India.
Indian J Anaesth. 2021 Jul;65(7):533-538. doi: 10.4103/ija.IJA_231_21. Epub 2021 Jul 23.
Despite advances in minimally invasive surgery, postoperative pain remains a concern after laparoscopic cholecystectomy. This study aims to compare the effect of intraperitoneal instillation of bupivacaine with alpha-2 agonists (dexmedetomidine and clonidine) for postoperative analgesia.
One hundred and eight patients scheduled for elective laparoscopic cholecystectomy were randomised to receive either 20 mL of 0.5% bupivacaine (Group B), 20 mL of 0.5% bupivacaine with dexmedetomidine 1 μg/kg (Group BD) or 20 mL of 0.5% bupivacaine with clonidine 1 μg/kg (Group BC). Study drug made to equal volume (40 mL) was instilled before the removal of trocar at the end of surgery. Standard general endotracheal anaesthesia with intra-abdominal pressure of 12-14 mm Hg during laparoscopy was followed uniformly. The primary objective of our study was the magnitude of pain. One way analysis of variance (ANOVA) for continuous variables and Chi-square test for categorical variables was used.
The Numerical Rating Scale (NRS) scores for pain intensity did not show any statistical significance at any of the pre-defined time points. Time to first request for analgesia was shortest in group BC (64.0 ± 60.6 min) when compared to the other groups (B, 78.8 ± 83.4 min; BD, 112.2 ± 93.4 min; < 0.05). Total amount of rescue fentanyl given in groups BD (16.8 ± 29.0 μg) and BC (15 ± 26.4 μg) was significantly less than B (35.7 ± 40.0 μg); < 0.05).
The addition of alpha-2 agonists to bupivacaine reduces the post-operative opioid consumption, and dexmedetomidine appears to be superior to clonidine in prolonging time to first analgesic request.
尽管微创手术取得了进展,但腹腔镜胆囊切除术后的疼痛仍是一个问题。本研究旨在比较布比卡因与α-2激动剂(右美托咪定和可乐定)腹腔内注入用于术后镇痛的效果。
108例计划行择期腹腔镜胆囊切除术的患者被随机分为三组,分别接受20 mL 0.5%布比卡因(B组)、20 mL含1 μg/kg右美托咪定的0.5%布比卡因(BD组)或20 mL含1 μg/kg可乐定的0.5%布比卡因(BC组)。在手术结束拔出套管针前,将制成等体积(40 mL)的研究药物注入腹腔。腹腔镜检查期间均采用标准全身气管内麻醉,腹内压维持在12 - 14 mmHg。本研究的主要目的是疼痛程度。连续变量采用单因素方差分析(ANOVA),分类变量采用卡方检验。
疼痛强度的数字评分量表(NRS)评分在任何预定义时间点均无统计学意义。与其他组相比,BC组首次要求镇痛的时间最短(64.0±60.6分钟)(B组为78.8±83.4分钟;BD组为112.2±93.4分钟;P<0.05)。BD组(16.8±29.0 μg)和BC组(15±26.4 μg)的挽救性芬太尼总量明显少于B组(35.7±40.0 μg);P<0.05)。
布比卡因中添加α-2激动剂可减少术后阿片类药物的用量,在延长首次镇痛请求时间方面,右美托咪定似乎优于可乐定。